Login / Signup
Response to Wynn and Hokovec Regarding "The Use of cfDNA to Screen for Monogenic Conditions in Low Risk Populations Is Ready for Clinical Use".
Neeta L Vora
Sylvie Langlois
Lyn S Chitty
Published in:
Prenatal diagnosis (2024)
Keyphrases
</>
high throughput